Xiangzhong C. Ye
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Immunogenicity and Safety of Two-dose Schedules With Different Intervals of an ORF7-deficient Live Vaccine Candidate for Varicella: A Randomized, Double-blind, Controlled, Phase 2b Trial.
Journal: The Pediatric infectious disease journal
Published: February 18, 2026
A randomized phase I trial of intranasal SARS-CoV-2 vaccine dNS1-RBD in children aged 3-17 years.
Journal: NPJ vaccines
Published: July 09, 2024
Broadly therapeutic antibody provides cross-serotype protection against enteroviruses via Fc effector functions and by mimicking SCARB2.
Journal: Nature microbiology
Published: December 15, 2023
Safety and efficacy of the intranasal spray SARS-CoV-2 vaccine dNS1-RBD: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Journal: The Lancet. Respiratory medicine
Published: May 31, 2023
A microfluidic system for rapid nucleic acid analysis based on real-time convective PCR at point-of-care testing.
Journal: Microfluidics and nanofluidics
Published: May 28, 2022
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockade.
Journal: Journal for immunotherapy of cancer
Published: May 06, 2022
A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2.
Journal: Science bulletin
Published: February 21, 2022
Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials.
Journal: The Lancet. Respiratory medicine
Published: November 16, 2021
Development of a skin- and neuro-attenuated live vaccine for varicella.
Journal: Nature communications
Published: July 05, 2021
A uniform quantitative enzyme-linked immunosorbent assay for Coxsackievirus A16 antigen in vaccine.
Journal: Human vaccines & immunotherapeutics
Published: August 05, 2020
Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating.
Journal: Cell host & microbe
Published: July 27, 2020
Last Updated: 09/26/2026